MedTrace Logo

Bioavailability of Orally Ingested Vitamin C

NCT05183880 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-05-16

No results posted yet for this study

Summary

The purpose of this study is to determine if crystalline vitamin C supplementation can acutely increase skeletal muscle vitamin C concentrations and if this can be potentiated by administering vitamin C using Phosphycell™ Technology - a phosphatidylcholine-lipid encapsulation technology.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Phosphatidylcholine-lipid encapsulated vitamin C

Ingesting 1000 mg of vitamin C in phosphatidylcholine-lipid encapsulated form

DIETARY_SUPPLEMENT

Crystalline vitamin C

Ingesting 1000 mg of vitamin C in crystalline form

Sponsors & Collaborators

  • University of Exeter

    lead OTHER

Principal Investigators

  • Francis Stephens · University of Exeter

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-26
Primary Completion
2022-11-26
Completion
2023-11-26

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05183880 on ClinicalTrials.gov